49 results on '"Donnici, Lorena"'
Search Results
2. Tracking the immune response profiles elicited by the BNT162b2 vaccine in COVID-19 unexperienced and experienced individuals
3. B cell analyses after SARS-CoV-2 mRNA third vaccination reveals a hybrid immunity like antibody response
4. Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody
5. Interferon‐inducible phospholipids govern IFITM3‐dependent endosomal antiviral immunity
6. Nirmatrelvir treatment of SARS‐CoV‐2‐infected mice blunts antiviral adaptive immune responses
7. Mapping of functional SARS-CoV-2 receptors in human lungs establishes differences in variant binding and SLC1A5 as a viral entry modulator of hACE2
8. Anti-spike antibodies and neutralising antibody activity in people living with HIV vaccinated with COVID-19 mRNA-1273 vaccine: a prospective single-centre cohort study
9. COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models
10. Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees
11. Publisher Correction: Novel interferon-sensitive genes unveiled by correlation-driven gene selection and systems biology
12. Novel interferon-sensitive genes unveiled by correlation-driven gene selection and systems biology
13. Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein
14. Isolation and Characterization of Neutralizing Monoclonal Antibodies from a Large Panel of Murine Antibodies against RBD of the SARS-CoV-2 Spike Protein.
15. Author Reply to Peer Reviews of Nirmatrelvir treatment blunts the development of antiviral adaptive immune responses in SARS-CoV-2 infected mice
16. Nirmatrelvir treatment blunts the development of antiviral adaptive immune responses in SARS-CoV-2 infected mice
17. Discovery and antiviral profile of new sulfamoylbenzamide derivatives as HBV capsid assembly modulators
18. Immunosuppressant Treatment in Rheumatic Musculoskeletal Diseases Does Not Inhibit Elicitation of Humoral Response to SARS-CoV-2 Infection and Preserves Effector Immune Cell Populations
19. COVID-19 mRNA third dose induces a unique hybrid immunity-like antibody response
20. Synthetic carbohydrate-binding agents neutralize SARS-CoV-2 by inhibiting binding of the spike protein to ACE2
21. Anatomy of Omicron neutralizing antibodies in COVID-19 mRNA vaccinees
22. Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion
23. DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic
24. Corrigendum to “DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic”
25. Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody
26. Integrated longitudinal immunophenotypic, transcriptional, and repertoire analyses delineate immune responses in patients with COVID-19
27. Controlled administration of aerosolized SARS-CoV-2 to K18-hACE2 transgenic mice uncouples respiratory infection and anosmia from fatal neuroinvasion
28. COVID-eVax, an electroporated plasmid DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain, elicits protective immune responses in animal models of COVID-19
29. Novel antiviral interferon sensitive genes unveiled by correlation-driven gene selection and integrated systems biology approaches
30. Synthetic Carbohydrate Binding Agents (CBAs) Prevent SARS-CoV-2 Entry by Inhibiting Binding of the Spike Protein to the ACE2 Receptor
31. Anti-Spike Antibodies and Neutralising Antibody Activity in People Living with HIV Vaccinated with COVID-19 mRNA-1273 Vaccine: A Prospective Cohort Study
32. Preparation of arylaminocarbonyl bicyclic sulfonamides as inhibitors of hepatitis B virus
33. Preparation of oxalamido-substituted tricyclic inhibitors of hepatitis B virus
34. Preparation of arylaminocarbonyl pyrrolo-fused tricyclic sulfonamides as inhibitors of hepatitis B virus
35. Preclinical assessment of capsid assembly modulators (CAMs) of varying potency revealed a novel class of picomolar-acting CAMs inducing neither significant HBcAg cytoplasmic retention nor adverse interactions with HBcAg-specific adaptive immunity
36. Nanoparticle‐Mediated Suicide Gene Therapy for Triple Negative Breast Cancer Treatment
37. Time-dependent biphasic modulation of human BDNF by antidepressants in neuroblastoma cells
38. AS001 - Preclinical assessment of capsid assembly modulators (CAMs) of varying potency revealed a novel class of picomolar-acting CAMs inducing neither significant HBcAg cytoplasmic retention nor adverse interactions with HBcAg-specific adaptive immunity
39. Hepatitis C Virus Deletion Mutants Are Found in Individuals Chronically Infected with Genotype 1 Hepatitis C Virus in Association with Age, High Viral Load and Liver Inflammatory Activity
40. Interaction between PNPLA3 I148M Variant and Age at Infection in Determining Fibrosis Progression in Chronic Hepatitis C
41. Interleukin 28B genotype and insulin resistance in chronic hepatitis C patients
42. Metabolism of Phosphatidylinositol 4-Kinase IIIα-Dependent PI4P Is Subverted by HCV and Is Targeted by a 4-Anilino Quinazoline with Antiviral Activity
43. Time-dependent biphasic modulation of human BDNF by antidepressants in neuroblastoma cells
44. Interaction between PNPLA3 I148M Variant and Age at Infection in Determining Fibrosis Progression in Chronic Hepatitis C.
45. Discovery and antiviral profile of new sulfamoylbenzamide derivatives as HBV capsid assembly modulators
46. Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion
47. Corrigendum to "DNA aptamers masking angiotensin converting enzyme 2 as an innovative way to treat SARS-CoV-2 pandemic".
48. Preclinical assessment of capsid assembly modulators (CAMs) of varying potency revealed a novel class of picomolar-acting CAMs inducing neither significant HBcAg cytoplasmic retention nor adverse interactions with HBcAg-specific adaptive immunity
49. Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.